Program
In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries
of innovation to design an event that works in today’s quickly changing environment.
In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or
watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.
Subgroup Analysis of Quality-of-Life Outcomes in Patients Achieving F-VASI75: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Speaker(s)
Pandya AG1, van Geel N2, Butler K3, Bibeau K3, Gao J3, Ezzedine K4
1Palo Alto Foundation Medical Group, Mountain View, CA, USA, and University of Texas Southwestern Medical Center, Dallas, TX, USA, 2Ghent University Hospital, Ghent, PA, Belgium, 3Incyte Corporation, Wilmington, DE, USA, 4Henri Mondor University Hospital and Université Paris-Est Créteil Val de Marne, Paris, France
Presentation Documents
Code
CO130
Topic
Clinical Outcomes, Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes, Performance-based Outcomes
Disease
No Additional Disease & Conditions/Specialized Treatment Areas